crdl stock price target

CRDL Stock Price Prediction. Stock news by MarketWatch.


Crdl To Stock Price Forecast Should You Buy Crdl To

CRDL stock price quote with breaking news financials statistics charts and more.

. 11289 Upside Based on 1 Wall Street analysts offering 12 month price targets for Cardiol Therapeutics in the last 3 months. View the best growth stocks for 2022 here. Cordel Groups stock was trading at GBX 763 at the beginning of 2022.

The average price target is 223 with a high. 061 000 000 Volume 207850 11022022 400PM Eastern Quotes. The forecasts range from a.

See more on advanced chart. 634a Tesla stock price target cut to 330 from 370 at Mizuho 633a DuPont stock price target cut to 79 from. Markets US Stocks Health Technology Biotechnology CRDL.

This is not a prediction by. Cardiol Therapeutics has a beta of -07 suggesting that its stock price is 170 less volatile than the SP 500. Their CRDL share price forecasts range from C300 to C800.

3 Wall Street analysts have issued 1-year price targets for Cardiol Therapeutics shares. Comparatively Titan Pharmaceuticals has a beta of 108. Analyst ratings historical stock prices earnings estimates actuals.

The average price target. Analyze Cardiol Therapeutics target price and analyst consensus to evaluate buy or sell recommendation on Cardiol Therapeutics. Stock Price Target CRDL.

Based on 1 Wall Street analysts offering 12 month price targets for Cardiol Therapeutics in the last 3 months. CRDL Complete Cardiol Therapeutics Inc. Get a real-time Cardiol Therapeutics Inc.

Based on short-term price targets offered by four analysts the average price target for Cardiol Therapeutics Inc. Since then CRDL stock has decreased by 148 and is now trading at GBX 650. Find the latest CARDIOL THERAPEUTICS INC CRDLTO analyst stock forecast price target and recommendation trends with in-depth analysis from research reports.

Get a real-time Cardiol Therapeutics Inc. The target price for CRDL stock is 396 based on the average of what a group of analyst think CRDL stock could be worth at a future date. Cardiol Therapeutics stock forecast analyst price target predictions based on 1 analysts offering 12-months price targets for CRDL in the last 3 months.

CRDL Stock Price Prediction. See CARDIOL THERAPEUTICS INC stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. USD 059 001 172.

How have CRDL shares performed in 2022. Stock Price Forecast. CRDL Stock Forecast Price Target for 2023 TradingView.

CRDL updated stock price target summary. According to 10 stock analysts the average 12-month stock price forecast for CRDL stock is 33 which predicts an increase of 51567.


Trevor Burns Trevorburns8 Twitter


Here S Why We Re Not Too Worried About Cardiol Therapeutics Tse Crdl Cash Burn Situation


Cardiol Therapeutics Inc Crdl Stock Price Quote News Stock Analysis


Trevor Burns Trevorburns8 Twitter


Crdl Cardiol Therapeutics Full Company Report Zacks Com


Cardiol Therapeutics Inc Superb Risk Reward Crdl Price Target Crdl Trend Analysis Crdl Update Youtube


Cardiol Therapeutics Inc Class A Stock Forecast Down To 0 000001 Usd Crdl Stock Price Prediction Long Term Short Term Share Revenue Prognosis With Smart Technical Analysis


Cardiol Therapeutics Inc Crdl Could Find Support Soon Here S Why You Should Buy The Stock Now Nasdaq


Crdl Cardiol Therapeutics Due Diligence Research Analysis R Fluentinfinance


Cardiol Therapeutics Inc Crdl Stock Price Quote News Stock Analysis


Crdl Cardiol Therapeutics Due Diligence Research Analysis R Fluentinfinance


Cardiol Therapeutics Has Price Target Trimmed At Altacorp Capital Cantech Letter


Tsx Crdl Stock Discussion Cardiol Therapeutics Inc


Cardiol Therapeutics Inc Tse Crdl Are Analysts Optimistic


Cardiol Therapeutics Stock Nasdaq Crdl Quotes And News Summary Benzinga


Jyvm34vog9vgym


Cardiol Therapeutics Inc Class A Common Shares Crdl Stock Price Quote News History Nasdaq


Crdl Cardiol Therapeutics Due Diligence Research Analysis R Fluentinfinance


Cardiol Therapeutics Inc Ceo Sees Bright Future For Pharmaceutically Produced Cannabidiol After Blockbuster Jazz Gw Pharmaceutical Deal

Iklan Atas Artikel

Iklan Tengah Artikel 1

Iklan Tengah Artikel 2

Iklan Bawah Artikel